Clinical Trials on Viral Wart in Peru

Total 131 results

University of California, Los Angeles
Universidad Peruana Cayetano Heredia; Espacio Comun

Completed

The Role of Genital Warts in HIV Acquisition in Peru (VIVA)

HIV | Anogenital Warts

Peru
MediGene

Completed

Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts

Condylomata Acuminata

United States, Argentina, Chile, Colombia, Mexico, Peru, Romania
University of Washington
GlaxoSmithKline; Asociación Civil Impacta Salud y Educación, Peru

Completed

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

HIV Infections | Sexually Transmitted Diseases | Herpes Simplex

Peru
University of Washington
GlaxoSmithKline; Asociación Civil Impacta Salud y Educación, Peru

Completed

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

HIV Infection | Sexually Transmitted Diseases | Herpes Simplex

Peru
Universidad Peruana Cayetano Heredia

Completed

PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19

COVID-19

Peru
Centre d'Expertise sur l'Altitude EXALT

Active, not recruiting

Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World (RINCOVID)

Covid19 | High Altitude

Peru
NGO Via Libre
University of Washington

Completed

Effect of an Online Video-Based Intervention to Increase HIV Testing in Men Who Have Sex With Men in Peru

HIV Infections

Peru
University of California, Los Angeles
Brown University; Asociación Civil Impacta Salud y Educación, Peru; The Fenway...

Completed

TransPrEP: Social Network-Based PrEP Adherence for Transgender Women in Peru (TransPrEP)

HIV Infection

Peru
Brigham and Women's Hospital
Harvard Medical School (HMS and HSDM); National Institute of Mental Health... and other collaborators

Completed

Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru (CASA)

HIV Infections | HIV | AIDS

Peru
Hospital Nacional Carlos Alberto Seguin Escobedo...

Completed

Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV) (TEDHICOV)

Covid19 | SARS-CoV Infection | Tenofovir

Peru
Universidad Peruana Cayetano Heredia
Fogarty International Center of the National Institute of Health

Completed

Evaluation of a Computer-Based System Using Cell Phones for HIV People in Peru (Cell-POS)

HIV Infections | HIV | Sexual Behavior | Adherence

Peru
Universidad Peruana Cayetano Heredia
London School of Hygiene and Tropical Medicine; Johns Hopkins University

Completed

Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients (WAYRA)

Covid19 | Mental Health Disorder | Respiratory Disease

Peru
The University of Texas Medical Branch, Galveston

Active, not recruiting

Strengthening Families Living With HIV in Kenya

PTSD | Hiv | Adherence, Medication | Depression, Anxiety | ART | Trust

Kenya
Universidad Peruana Cayetano Heredia
Fogarty International Center of the National Institute of Health

Active, not recruiting

A Mobile Phone SMS Intervention to Increase Retention in HIV Care Among HIV-Positive MSM in Peru (WELTEL PERU)

Hiv | Retention in Care

Peru
Universidad Peruana Cayetano Heredia
Barcelona Institute for Global Health

Completed

Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 (SAINT-PERU)

Coronavirus Infection | Covid19 | SARS-CoV Infection

Peru
Universidad Peruana Cayetano Heredia
University of Minnesota; Hospital Nacional Alberto Sabogal Sologuren

Recruiting

CBT and Quality of Life of People With HIV, COVID-19 and Anxiety or Depression (COVIHMENT-19)

Depression | Quality of Life | Anxiety

Peru
Universidad Peruana Cayetano Heredia

Completed

Hydroxychloroquine to Prevent SARS-CoV-2 Infection/COVID-19

SARS-CoV-2

Peru
National Institute of Allergy and Infectious Diseases...
Comprehensive International Program of Research on AIDS

Completed

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

HIV Infections | Herpesvirus 2, Human

Peru
Fred Hutchinson Cancer Center
National Institute on Drug Abuse (NIDA); University of Washington; Seattle Children... and other collaborators

Completed

Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use (MERLIN)

HIV Infection

Peru
Harvard University Faculty of Medicine
National Institute of Mental Health (NIMH)

Recruiting

PASEO Intervention for Adolescents Transitioning to Adult HIV Care in Urban Peru (PASEO)

HIV Infections

Peru
Universidad Peruana Cayetano Heredia

Active, not recruiting

Long-term Impact on Cardiopulmonary Function and Quality of Life in Patients Recovered From COVID-19. (FUNCTION)

COVID-19

Peru
Sanofi Pasteur, a Sanofi Company

Completed

Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers

Yellow Fever | Dengue | Dengue Hemorrhagic Fever

Peru, Colombia
Sanofi Pasteur, a Sanofi Company

Completed

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type b

Peru
Duke University
United States Agency for International Development (USAID); Universidad Peruana...

Completed

Identification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Telemedicine

HIV Infections | Cervical Cancer | HPV Infection

Peru
Universidad Peruana Cayetano Heredia
National University of San Marcos, Peru

Completed

Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru (Covid-Peru)

COVID-19

Peru
Sanofi Pasteur, a Sanofi Company

Completed

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Peru
CureVac
German Federal Ministry of Education and Research

Completed

A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus

Panama, Peru
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Prepare for Future HIV Vaccine Studies

HIV Infections

Haiti, Peru
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Durability of Adherence in Self-Management of HIV (DASH)

HIV Infections

Peru, United States
National Institute of Allergy and Infectious Diseases...
Comprehensive International Program of Research on AIDS

Completed

Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador

HIV Infections | Sexually Transmitted Diseases | Syphilis

Ecuador, Peru
Sanofi Pasteur, a Sanofi Company

Completed

Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type b

Peru, Mexico
St. Petersburg Research Institute of Vaccines and...

Recruiting

Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children

Vaccine Reaction | Influenza | Influenza, Human | Influenza Viral Infections

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

Acute Respiratory Viral Infections

Russian Federation, Kazakhstan
Valenta Pharm JSC

Completed

A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Influenza | Respiratory Viral Infection

Russian Federation
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People (FASTER)

HIV Infections

Peru, Brazil, South Africa
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.; Sciwind Biosciences USA Co., Ltd.

Withdrawn

Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy

COVID-19 Acute Respiratory Distress Syndrome

Argentina, Peru
St. Petersburg Research Institute of Vaccines and...

Completed

Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine

Vaccine Reaction | Influenza | Influenza, Human | Vaccination; Infection | Influenza Viral Infections

Russian Federation
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Evandro Chagas National Institute of Infectious... and other collaborators

Active, not recruiting

Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial (OPTIMO)

HIV Infection

Peru, Brazil, Haiti
Materia Medica Holding

Completed

Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old

Acute Respiratory Viral Infection

Russian Federation
Valenta Pharm JSC

Recruiting

Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

Acute Respiratory Infection

Russian Federation
Human Stem Cell Institute, Russia
Betuvax LLC; CEG BIO LLC

Active, not recruiting

Safety, Tolerability and Immunogenicity of Recombinant COVID-19 Vaccine Betuvax-CoV-2 (Betuvax-CoV2)

COVID-19

Russian Federation
P95
Centers for Disease Control and Prevention, China

Completed

Effectiveness of Chinese COVID-19 Vaccines in Latin America and the Caribbean

COVID-19

Argentina, Colombia, Dominican Republic, Peru
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults

HIV Infections

United States, Peru
National Institute of Allergy and Infectious Diseases...

Completed

Antigenic Competition in HIV Preventive Vaccines

HIV Infections

United States, Peru, Switzerland, Brazil
National Institute of Allergy and Infectious Diseases...

Completed

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

HIV Infections | HIV Seronegativity

Brazil, Peru, Haiti, Trinidad and Tobago
Chumakov Federal Scientific Center for Research...

Active, not recruiting

An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine (CoviVac) for Adults Aged 60 Years and Older

COVID-19 | Corona Virus Infection | Vaccine

Russian Federation
Promomed, LLC

Completed

Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis

COVID-19

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.

Influenza, Human | Common Cold | Acute Respiratory Infection | Viral Infection

Russian Federation
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205

HIV Infections

United States, Peru
Valenta Pharm JSC

Completed

Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation

Clinical Trials on Viral Wart in Peru

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations